Jun Urano

USPTO Granted Patents = 16 (Patent Applications = 21)

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 113(Granted Patents)

Location History:

Englewood, CO (US) (2012)
Aurora, CO (US) (2011 - 2018)
Irvine, CA (US) (2012 - 2024)

Company Filing History:

Synthetic Genomics, Inc.

California Institute of Technology

patents

5. 1 out of 1

Synthetics Genomics, Inc.

patent

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11873497 - Regulatory elements from labyrinthulomycetes microorganisms (2024-01-16),

2. 10633665 - Regulatory elements from labyrinthulomycetes microorganisms (2020-04-28),

3. 10584347 - Production of proteins in labyrinthulomycetes (2020-03-10),

4. 10131897 - Molecules associated with fatty acid biosynthetic pathways and uses thereof (2018-11-20),

5. 9932599 - Regulatory elements from labyrinthulomycetes microorganisms (2018-04-03),

6. 9926577 - Yeast organism producing isobutanol at a high yield (2018-03-27),

7. 9546372 - Regulatory elements and uses thereof (2017-01-17),

8. 9506074 - Yeast microorganisms with reduced by-product accumulation for improved production of fuels, chemicals, and amino acids (2016-11-29),

9. 9441238 - Compositions and methods for modulating the sensitivity of cells to AHAS inhibitors (2016-09-13),

10. 8614077 - Recovery of higher alcohols from dilute aqueous solutions (2013-12-24),

11. 8455239 - Yeast organism producing isobutanol at a high yield (2013-06-04),

12. 8232089 - Cytosolic isobutanol pathway localization for the production of isobutanol (2012-07-31),

13. 8153415 - Reduced by-product accumulation for improved production of isobutanol (2012-04-10),

14. 8133715 - Reduced by-product accumulation for improved production of isobutanol (2012-03-13),

15. 8097440 - Engineered microorganisms capable of producing target compounds under anaerobic conditions (2012-01-17),

Title: Innovator Spotlight: Jun Urano

Introduction

Jun Urano is a distinguished inventor based in Irvine, California. With a remarkable portfolio of 16 patents, he has significantly contributed to the field of biotechnology. His work primarily focuses on novel polynucleotide molecules for regulating gene expression in recombinant cells, particularly those derived from labyrinthulomycetes microorganisms.

Latest Patents

Among his latest innovations, Urano has developed groundbreaking methods and constructs that include regulatory elements for use in recombinant cells. His patents encompass nucleic acid constructs, such as vectors and expression cassettes, which contain operable regulatory elements linked to heterologous nucleotide sequences. Furthermore, he has explored methods for the stable transformation of host cells, enabling advancements in genetic engineering. His work has resulted in stably transformed recombinant cells and methodologies for preparing and utilizing biomaterials derived from these innovations.

Career Highlights

Urano has applied his expertise at several notable companies, including Gevo, Inc. and Synthetic Genomics, Inc. His time at these organizations has allowed him to collaborate on transformative projects that push the boundaries of biotechnology and genetic research.

Collaborations

Throughout his career, Jun Urano has worked alongside accomplished professionals, including Peter Meinhold and Catherine Asleson Dundon. These collaborations have enriched his research and development efforts, fostering an environment of innovation and discovery.

Conclusion

Jun Urano exemplifies the spirit of innovation in biotechnology. His extensive patent portfolio and collaborations signify his commitment to advancing the field. As he continues to innovate, the impact of his work is likely to resonate throughout the industry and beyond.

This text is generated by artificial intelligence and may not be accurate.